NEW YORK - Lucid Diagnostics Inc. (NASDAQ:LUCD) announced Tuesday results from what it describes as the largest real-world experience of non-endoscopic esophageal precancer detection using its ...
Heartburn is something almost everyone experiences at some point. For many, it is an occasional discomfort after a heavy meal, late-night snacking or a highly stressful day. To some, heartburn becomes ...
RAHWAY, N.J., December 17, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial ...
Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with ...
Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...
Carley Millhone is a writer and editor based in the Midwest who covers health, women's wellness, and travel. Her work has appeared in publications like SELF, Greatist, and PureWow. Jay N. Yepuri, MD, ...
Shunting in NPH, a novel drug for narcolepsy, and new approaches in multiple sclerosis are among the top picks from Professor Diener.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback